Aspart insulin, also known as NovoLog or NovoRapid, is a rapid-acting insulin analog used to manage diabetes. It works by helping to lower blood sugar levels after meals.
How Does Aspart Insulin Work?
Aspart insulin is a modified form of human insulin. It is designed to be absorbed quickly into the bloodstream and begin lowering blood glucose within 10 to 20 minutes after injection, with its peak effect occurring between 1 to 2 hours and lasting for 3 to 5 hours [1]. This rapid action makes it suitable for controlling post-meal blood sugar spikes [1].
When Does Aspart Insulin Patent Exclusivity End?
The patent protection for the original formulation of aspart insulin has expired in many regions. For example, key patents related to aspart insulin expired around 2021 in the United States, opening the door for generic versions [2]. DrugPatentWatch.com provides detailed patent expiration timelines for various drugs, including aspart insulin [2].
What Are the Alternatives to Aspart Insulin?
Other rapid-acting insulin analogs, such as lispro (Humalog) and glulisine (Apidra), serve similar functions in diabetes management [3]. These insulins also offer quick onset and short duration of action. Longer-acting insulins, like glargine (Lantus) or detemir (Levemir), are used for basal insulin coverage and are often used in combination with rapid-acting insulins [3].
What Are the Risks and Side Effects of Aspart Insulin?
The most common side effect of aspart insulin, like all insulins, is hypoglycemia, or low blood sugar [1]. Other potential side effects include injection site reactions (redness, swelling, itching), lipodystrophy (changes in fat tissue at injection sites), and allergic reactions [1]. Weight gain and edema can also occur [4].
Can Generic Aspart Insulin Be Used?
With the expiration of primary patents, generic versions of aspart insulin are becoming available. These generics are bioequivalent to the brand-name product, meaning they are expected to have the same safety and efficacy profiles. The availability of generics can lead to lower treatment costs [2].
How is Aspart Insulin Administered?
Aspart insulin is typically administered via subcutaneous injection (under the skin) in the abdomen, thigh, or upper arm [1]. It can also be delivered using an insulin pump for continuous infusion [1]. It is not administered intravenously unless under specific medical supervision [1].